Inhibition of Chk1 Kills Tetraploid Tumor Cells through a p53-Dependent Pathway
Open accessThe DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index.
Abstract
Tetraploidy constitutes an adaptation to stress and an intermediate step between euploidy and aneuploidy in oncogenesis. Tetraploid cells are particularly resistant against genotoxic stress including radiotherapy and chemotherapy. Here, we designed a strategy to preferentially kill tetraploid tumor cells. Depletion of checkpoint kinase-1 (Chk1) by siRNAs, transfection with dominant-negative Chk1 mutants or pharmacological Chk1 inhibition killed tetraploid colon cancer cells yet had minor effects on their diploid counterparts. Chk1 inhibition abolished the spindle assembly checkpoint and caused premature and abnormal mitoses that led to p53 activation and cell death at a higher frequency in tetraploid than in diploid cells. Similarly, abolition of the spindle checkpoint by knockdown of Bub1, BubR1 or Mad2 induced p53-dependent apoptosis of tetraploid cells. Chk1 inhibition reversed the cisplatin resistance of tetraploid cells in vitro and in vivo, in xenografted human cancers. Chk1 inhibition activated p53-regulated transcripts including Puma/BBC3 in tetraploid but not in diploid tumor cells. Altogether, our results demonstrate that, in tetraploid tumor cells, the inhibition of Chk1 sequentially triggers aberrant mitosis, p53 activation and Puma/BBC3-dependent mitochondrial apoptosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Of note, the primary alterations that drive catastrophic mitoses can originate in other phases of the cell cycles, including the S phase (e.g., a premature entry in mitosis caused by failure of the intra-S-phase checkpoint) [979, 980].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [980]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456 · cited 1×
“As a control, a siRNA specific for emerin [56] as well as unrelated control siRNAs (scramble, SCR) were used.”
MethodCalreticulin exposure dictates the immunogenicity of cancer cell death
Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216 · cited 1×
“c in 200 ml of PBS with 3610(6) diploid or tetraploid HCT116 cells into the lower flank as previously described [60].”
MethodSelf-citationDNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688 · cited 2×
“activation of Chk2 helps in the elimination of potentially malignant cells [18,19], and that familial loss-of-function muta-”
BackgroundDNA methylation and epigenetic inheritance
Holliday, R. (1990) · Philosophical Transactions of the Royal Society of London. B, Biological Sciences · doi:10.1098/rstb.1990.0015 · Cited by 2,279
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009 · cited 2×
“activation of Chk2 helps in the elimination of potentially malignant cells [18,19], and that familial loss-of-function muta-”
BackgroundCell death by mitotic catastrophe: a molecular definition
Castedo, M., Perfettini, J.-L., Roumier, T., Andreau, K., Medema, R., & Kroemer, G. (2004) · Oncogene · doi:10.1038/sj.onc.1207528 · Cited by 1,269 · cited 1×
“activation of pro-apoptotic genes that cause the elimination of the tetraploid cell by programmed cell death [7,8,12,13].”
BackgroundSelf-citationATR-Mediated Checkpoint Pathways Regulate Phosphorylation and Activation of Human Chk1
Zhao, H., & Piwnica-Worms, H. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.13.4129-4139.2001 · Cited by 1,091 · cited 1×
“The DNA damage-elicited kinase ATR is elicited by cisplatin [48,49] and may participate in the activation of Chk1, which in turn mediates the cisplatin-induced cell cycle arrest [50,51].”
BackgroundCytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells
Fujiwara, T., Bandi, M., Nitta, M., Ivanova, E. V., Bronson, R. T., & Pellman, D. (2005) · Nature · doi:10.1038/nature04217 · Cited by 1,067 · cited 1×
“Experimental tetraploidization of p53-negative mammary epithelial cells can be employed as a method to generate transformed, tumorigenic cells, thus providing a proof-of-principle that tetraploidization may constitute an important intermediate step in carcinogenesis [5].”
BackgroundShieh, S.-Y., Ahn, J., Tamai, K., Taya, Y., & Prives, C. (2000) · Genes & Development · doi:10.1101/gad.14.3.289 · Cited by 972 · cited 1×
“First, Chk1 activation reportedly causes the phosphorylation of p53, resulting in its stabilization and its transcriptional activation [37].”
BackgroundFrom polyploidy to aneuploidy, genome instability and cancer
Storchova, Z., & Pellman, D. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1276 · Cited by 810 · cited 1×
“. Tetraploid cells then can undergo asymmetric cell division and/or chromosome loss, leading to aneuploidization and chromosomal instability”
Background
Cited by
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
“, a premature entry in mitosis caused by failure of the intra-S-phase checkpoint) [979, 980].”
BackgroundSelf-citationMolecular mechanisms of cisplatin resistance
Galluzzi, L., Senovilla, L., Vitale, I., Michels, J., Martins, I., Kepp, O., Castedo, M., & Kroemer, G. (2012) · Oncogene · doi:10.1038/onc.2011.384 · Cited by 2,760
“This phenomenon can be reverted by the depletion/inhibition of TP53, its target ribonucleotide reductase M2 B (RRM2B) or CHEK1 (Castedo et al., 2006; Vitale et al., 2007), implying that the cisplatinresistant phenotype of tetraploid cancer cells relies on complex mechanisms that go beyond a merely…”
BackgroundInfluentialSelf-citationDissecting the genomic complexity underlying medulloblastoma
Jones, D. T. W., Jäger, N., Kool, M., Zichner, T., Hutter, B., Sultan, M., Cho, Y.-J., Pugh, T. J., Hovestadt, V., Stütz, A. M., et al. (2012) · Nature · doi:10.1038/nature11284 · Cited by 839
Mitotic catastrophe: a mechanism for avoiding genomic instability
Vitale, I., Galluzzi, L., Castedo, M., & Kroemer, G. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3115 · Cited by 834
“This can directly stimulate the mitotic death programme of mitotic catastrophe or lead to the generation of multinucleated (mostly binucleated) tetraploid cells, which are intrinsically more prone to mitotic aberrations (and hence to mitotic catastrophe) than their diploid counterpart”
BackgroundSelf-citationSystems biology of cisplatin resistance: past, present and future
Galluzzi, L., Vitale, I., Michels, J., Brenner, C., Szabadkai, G., Harel-Bellan, A., Castedo, M., & Kroemer, G. (2014) · Cell Death & Disease · doi:10.1038/cddis.2013.428 · Cited by 782
Self-citationGuidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes
Galluzzi, L., Aaronson, S. A., Abrams, J., Alnemri, E. S., Andrews, D. W., Baehrecke, E. H., Bazan, N. G., Blagosklonny, M. V., Blomgren, K., Borner, C., et al. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2009.44 · Cited by 680
Self-citationDeath through a tragedy: mitotic catastrophe
Vakifahmetoglu, H., Olsson, M., & Zhivotovsky, B. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.47 · Cited by 700
Medulloblastomics: the end of the beginning
Northcott, P. A., Jones, D. T. W., Kool, M., Robinson, G. W., Gilbertson, R. J., Cho, Y.-J., Pomeroy, S. L., Korshunov, A., Lichter, P., Taylor, M. D., et al. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3410 · Cited by 663
Morselli, E., Maiuri, M. C., Markaki, M., Megalou, E., Pasparaki, A., Palikaras, K., Criollo, A., Galluzzi, L., Malik, S. A., Vitale, I., et al. (2010) · Cell Death & Disease · doi:10.1038/cddis.2009.8 · Cited by 613
“A total of 50mg of proteins were then separated on 10% SDS-PAGE pre-cast gels (Invitrogen) and electrotransferred to Immobilon membranes (Millipore Corporation, Billerica, MA, USA), according to standard procedures.(45,46) Unspecific binding sites were saturated by incubating membranes for 1 h in 0.”
MethodSelf-citationmiR-181a and miR-630 Regulate Cisplatin-Induced Cancer Cell Death
Galluzzi, L., Morselli, E., Vitale, I., Kepp, O., Senovilla, L., Criollo, A., Servant, N., Paccard, C., Hupé, P., Robert, T., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3112 · Cited by 280
Self-citationWhole-genome doubling confers unique genetic vulnerabilities on tumour cells
Quinton, R. J., DiDomizio, A., Vittoria, M. A., Kotýnková, K., Ticas, C. J., Patel, S., Koga, Y., Vakhshoorzadeh, J., Hermance, N., Kuroda, T. S., et al. (2021) · Nature · doi:10.1038/s41586-020-03133-3 · Cited by 274
Aylon, Y., & Oren, M. (2011) · Molecular Oncology · doi:10.1016/j.molonc.2011.07.007 · Cited by 190
“Moreover, the (rare) survival of p53-proficient tetraploid cells strongly depends on the activity of the checkpoint kinase Chk1 (Vitale et al., 2007).”
BackgroundInfluentialSize Does Matter: Why Polyploid Tumor Cells are Critical Drug Targets in the War on Cancer
Coward, J., & Harding, A. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00123 · Cited by 192
Targeting the DNA Damage Response in Cancer
Ljungman, M. (2009) · Chemical Reviews · doi:10.1021/cr900047g · Cited by 163
Illicit survival of cancer cells during polyploidization and depolyploidization
Vitale, I., Galluzzi, L., Senovilla, L., Criollo, A., Jemaà, M., Castedo, M., & Kroemer, G. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2010.145 · Cited by 159
“Accordingly, inhibition/depletion of SAC components preferentially kills tetraploids.(67)”
BackgroundSelf-citationTrial Watch: Targeting ATM–CHK2 and ATR–CHK1 pathways for anticancer therapy
Manic, G., Obrist, F., Sistigu, A., & Vitale, I. (2015) · Molecular & Cellular Oncology · doi:10.1080/23723556.2015.1012976 · Cited by 163
“Intriguingly, inactivation of CHK1, ATM, and ATR displayed enhanced anticancer activity in hypoxic conditions, most likely due to the role of DDR in hypoxia/reoxygenation,(203-205) whereas CHK1 inhibitors demonstrated preferential activity against genomically unstable polyploid cells.(206) Finally, pharmacologic inact…”
BackgroundSelf-citationMultipolar mitosis of tetraploid cells: inhibition by p53 and dependency on Mos
Vitale, I., Senovilla, L., Jemaà, M., Michaud, M., Galluzzi, L., Kepp, O., Nanty, L., Criollo, A., Rello‐Varona, S., Manic, G., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.11 · Cited by 146
“Immunofluorescence microscopy determinations were performed as previously described (Vitale et al, 2007, 2008).”
MethodSelf-citationA link between mitotic defects and mitotic catastrophe: detection and cell fate
Sazonova, E. V., Petrichuk, S. V., Kopeina, G. S., & Zhivotovsky, B. (2021) · Biology Direct · doi:10.1186/s13062-021-00313-7 · Cited by 155
“cause of changes that lead to irreversible cell cycle arrest and mitotic catastrophe [11, 12].”
BackgroundPrognostic Impact of Vitamin B6 Metabolism in Lung Cancer
Galluzzi, L., Vitale, I., Senovilla, L., Olaussen, K. A., Pinna, G., Eisenberg, T., Goubar, A., Martins, I., Michels, J., Kratassiouk, G., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.06.017 · Cited by 131
Self-citationThe impact of p53 and p73 on aneuploidy and cancer
Tomasini, R., Mak, T. W., & Melino, G. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.03.003 · Cited by 142
Hoffmann, J., Vitale, I., Buchmann, B., Galluzzi, L., Schwede, W., Senovilla, L., Skuballa, W., Vivet, S., Lichtner, R. B., Vicencio, J. M., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0237 · Cited by 104
Self-citationPolyploidy formation in cancer cells: How a Trojan horse is born
Waś, H., Borkowska, A., Olszewska, A., Klemba, A., Marciniak, M., Synowiec, A., & Kiéda, C. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.03.003 · Cited by 106
Prognosis, Biology, and Targeting of TP53 Dysregulation in Multiple Myeloma
Flynt, E., Bisht, K. K., Sridharan, V., Ortiz, M., Towfic, F., & Thakurta, A. (2020) · Cells · doi:10.3390/cells9020287 · Cited by 86
Mirza-Aghazadeh-Attari, M., Darband, S. G., Kaviani, M., Mihanfar, A., Aghazadeh Attari, J., Yousefi, B., & Majidinia, M. (2018) · DNA Repair · doi:10.1016/j.dnarep.2018.07.005 · Cited by 76
Resveratrol and aspirin eliminate tetraploid cells for anticancer chemoprevention
Lissa, D., Senovilla, L., Rello-Varona, S., Vitale, I., Michaud, M., Pietrocola, F., Boilève, A., Obrist, F., Bordenave, C., Garcia, P., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318440111 · Cited by 72
“Tetraploid cells are intrinsically resistant against DNA damaging agents (9), yet are more susceptible to a variety of agents including inhibitors of checkpoint kinase 1 (19), Aurora kinase B (20), and mitotic kinesins (21, 22).”
BackgroundSelf-citationAbnormal mitosis triggers p53-dependent cell cycle arrest in human tetraploid cells
Kuffer, C., Kuznetsova, A. Y., & Štorchová, Z. (2013) · Chromosoma · doi:10.1007/s00412-013-0414-0 · Cited by 81
“1999) and the DNA damage-responsive kinases ATM, Chk1, and Chk2 that have also been linked to mitotic defects (Vitale et al. 2007; Li et al. 2010; Stolz et al. 2010).”
BackgroundTargeting tumor cell senescence and polyploidy as potential therapeutic strategies
Saleh, T., Carpenter, V. J., Bloukh, S., & Gewirtz, D. A. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.12.010 · Cited by 74
Antineoplastic activity of ouabain and pyrithione zinc in acute myeloid leukemia
Tailler, M., Senovilla, L., Lainey, É., Thépot, S., Métivier, D., Sébert, M., Baud, V., Billot, K., Fenaux, P., Galluzzi, L., et al. (2011) · Oncogene · doi:10.1038/onc.2011.521 · Cited by 70
“Immunofluorescence microscopy Immunofluorescence microscopy studies were performed as previously reported (Vitale et al., 2007).”
MethodSelf-citationOlaussen, K. A., Commo, F., Tailler, M., Lacroix, L., Vitale, I., Raza, S. Q., Richon, C., Dessen, P., Lazar, V., Soria, J., et al. (2009) · Oncogene · doi:10.1038/onc.2009.277 · Cited by 65
“We reasoned that it would be important to define transcriptome changes that occur during the proapoptotic signaling phase rather than those occurring during the execution of the apoptotic program (Castedo et al., 2006; Vitale et al., 2007; de La Motte Rouge et al., 2007), when RNAs (Houge et al.”
BackgroundSelf-citationCell Death Signaling and Anticancer Therapy
Galluzzi, L., Vitale, I., Vacchelli, E., & Kroemer, G. (2011) · Frontiers in Oncology · doi:10.3389/fonc.2011.00005 · Cited by 65
“…defects or misattached chromosomes (Musacchio and Salmon, 2007); (iii) the activity of the tumor suppressor protein TP53 (Castedo et al., 2006; Vitale et al., 2007; Huang et al., 2009); and (iv) aberrantly high levels of cyclin B1, leading to prolonged activation of the cyclin-dependent…”
BackgroundSelf-citationSelective killing of p53‐deficient cancer cells by SP600125
Jèmaà, M., Vitale, I., Kepp, O., Berardinelli, F., Galluzzi, L., Senovilla, L., Mariño, G., Malik, S. A., Rello‐Varona, S., Lissa, D., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201200228 · Cited by 65
Self-citationMolecular Regulation of the Spindle Assembly Checkpoint by Kinases and Phosphatases
Manic, G., Corradi, F., Sistigu, A., Siteni, S., & Vitale, I. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2016.08.004 · Cited by 65
Self-citationZhang, C., Yan, Z., Painter, C. L., Zhang, Q., Chen, E., Arango, M. E., Kuszpit, K. K., Zasadny, K. R., Hallin, M. E., Hallin, J. F., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3272 · Cited by 63
Disruption of the PP1/GADD34 complex induces calreticulin exposure
Kepp, O., Galluzzi, L., Giordanetto, F., Tesnière, A., Vitale, I., Martins, I., Schlemmer, F., Adjemian, S., Zitvogel, L., & Kroemer, G. (2009) · Cell Cycle · doi:10.4161/cc.8.23.10191 · Cited by 60
Self-citationAn automated fluorescence videomicroscopy assay for the detection of mitotic catastrophe
Rello‐Varona, S., Kepp, O., Vitale, I., Michaud, M., Senovilla, L., Jèmaà, M., Joza, N. A., Galluzzi, L., Castedo, M., & Kroemer, G. (2010) · Cell Death and Disease · doi:10.1038/cddis.2010.6 · Cited by 48
“In line with this hypothesis, we have previously shown that the inhibition of mitotic catastrophe increases the propensity of cells to enter multipolar, asymmetric divisions that eventually lead to aneuploidy.12 In addition, mitotic catastrophe can be induced by exogenous agents including ionizing irradiation,28 micro…”
BackgroundSelf-citationLainey, É., Wolfromm, A., Sukkurwala, A. Q., Micol, J., Fenaux, P., Galluzzi, L., Kepp, O., & Kroemer, G. (2013) · Cell Cycle · doi:10.4161/cc.26016 · Cited by 45
“Cytofluorometric assessment of apoptosis and cell cycle distribution For apoptosis determinations, cells were co-stained with 1 μg/mL propidium iodide (PI) (Sigma-Aldrich), which identifies cells with ruptured plasma membranes, and either 20 nM 3,3′dihexiloxalocarbocyanine iodide (DiOC 6 (3); Molecular Probes-Life Tec…”
MethodSelf-citationWhole-genome duplication increases tumor cell sensitivity to MPS1 inhibition
Jèmaà, M., Manic, G., Lledo, G., Lissa, D., Reynès, C., Morin, N., Chibon, F., Sistigu, A., Castedo, M., Vitale, I., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6432 · Cited by 43
“…or selectively succumb to the inhibition of cell cycle or mitotic regulators, including checkpoint kinase 1 (CHEK1, best known as CHK1) [20], aurora kinase B (AURKB) [45], and kinesin family member 11 (KIF11, best known as EG5) [46], but also to antioxidants [47], and to perturbations…”
Self-citationHyperdiploid tumor cells increase phenotypic heterogeneity within Glioblastoma tumors
Donovan, P., Cato, K., Legaie, R., Jayalath, R., Olsson, G., Hall, B. I., Olson, S., Boros, S., Reynolds, B. A., & Harding, A. S. (2014) · Molecular BioSystems · doi:10.1039/c3mb70484j · Cited by 42
Yeung, Y. T., Yin, S., Lu, B., Fan, S., Yang, R., Bai, R., Zhang, C., Bode, A. M., Liu, K., & Dong, Z. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.01.017 · Cited by 41
Wavelet feature extraction and genetic algorithm for biomarker detection in colorectal cancer data
Liu, Y., Aickelin, U., Feyereisl, J., & Durrant, L. G. (2012) · Knowledge-Based Systems · doi:10.1016/j.knosys.2012.09.011 · Cited by 38
Preferential killing of p53-deficient cancer cells by reversine
Jèmaà, M., Galluzzi, L., Kepp, O., Boilève, A., Lissa, D., Senovilla, L., Harper, F., Pierron, G., Berardinelli, F., Antoccia, A., et al. (2012) · Cell Cycle · doi:10.4161/cc.20621 · Cited by 40
Self-citationCaspase 2 in mitotic catastrophe: The terminator of aneuploid and tetraploid cells
Vitale, I., Manic, G., Castedo, M., & Kroemer, G. (2017) · Molecular & Cellular Oncology · doi:10.1080/23723556.2017.1299274 · Cited by 35
Self-citationKaryotypic Aberrations in Oncogenesis and Cancer Therapy
Vitale, I., Manic, G., Senovilla, L., Kroemer, G., & Galluzzi, L. (2015) · Trends in Cancer · doi:10.1016/j.trecan.2015.08.001 · Cited by 34
“shRNA BUBR1 Inhibition of BUBR1 promoted TP53dependent cell death in polyploid cells [76,82]”
BackgroundSelf-citationChk1 inhibition activates p53 through p38 MAPK in tetraploid cancer cells
Vitale, I., Senovilla, L., Galluzzi, L., Criollo, A., Vivet, S., Castedo, M., & Kroemer, G. (2008) · Cell Cycle · doi:10.4161/cc.7.13.6073 · Cited by 34
Self-citationTwo 4N Cell-Cycle Arrests Contribute to Cisplatin-Resistance
Shen, H., Perez, R. E., Davaadelger, B., & Maki, C. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059848 · Cited by 38
“showed this dose inhibits Chk1 and sensitizes cells to CP [28], and”
BackgroundWang, Q., Lu, F., & Lan, R. (2017) · Molecular BioSystems · doi:10.1039/c7mb00334j · Cited by 26
Galofré, C., Geyik, Ö. G., Asensio, E., Wangsa, D., Hirsch, D. D., Parra, C., Sáez, J., Mollà, M., Yüce, Z., Castells, A., et al. (2020) · Cancers · doi:10.3390/cancers12051118 · Cited by 27
“Of note, inhibition of CHK1 was suggested to eradicate tetraploid tumor cells through a p53-dependent pathway [21].”
BackgroundGRP78/BiP determines senescence evasion cell fate after cisplatin-based chemotherapy
Zin, Z., Choochuay, K., Tubsuwan, A., Pinkaew, D., Suksomtip, M., Vinayanuwattikun, C., Chanvorachote, P., & Chunhacha, P. (2021) · Scientific Reports · doi:10.1038/s41598-021-01540-8 · Cited by 25
Cell death classification: A new insight based on molecular mechanisms
Dehghan, S., Kheshtchin, N., Hassannezhad, S., & Soleimani, M. (2023) · Experimental Cell Research · doi:10.1016/j.yexcr.2023.113860 · Cited by 23
Zhang, D., Zhang, J., Mao, L., Wu, J., Cao, W., Zheng, J., & Pei, D. (2015) · Tumor Biology · doi:10.1007/s13277-014-3007-5 · Cited by 21
Cytofluorometric Assessment of Cell Cycle Progression
Vitale, I., Jèmaà, M., Galluzzi, L., Métivier, D., Castedo, M., & Kroemer, G. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-239-1_6 · Cited by 15
Self-citationBrf1 loss and not overexpression disrupts tissues homeostasis in the intestine, liver and pancreas
Liko, D., Mitchell, L. E., Campbell, K. J., Ridgway, R. A., Jones, C., Dudek, K., King, A., Bryson, S., Stevenson, D., Blyth, K., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0316-7 · Cited by 15
Involvement of p38α in the mitotic progression ofp53-/-tetraploid cells
Vitale, I., Jèmaà, M., Senovilla, L., Galluzzi, L., Rello‐Varona, S., Métivier, D., Ripoche, H., Lazar, V., Dessen, P., Castedo, M., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.14.12254 · Cited by 14
Self-citationDeberne, M., Lévy, A., Mondini, M., Dessen, P., Vivet, S., Supiramaniam, A., Vozenin, M., & Deutsch, É. (2013) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e3283612a71 · Cited by 15
Self-citationTomita, M., Tanaka, Y., & Mori, N. (2010) · International Journal of Cancer · doi:10.1002/ijc.25178 · Cited by 12
RetractedJèmaà, M., Galluzzi, L., Kepp, O., Castedo, M., Rello‐Varona, S., Vitale, I., & Kroemer, G. (2012) · Cell Cycle · doi:10.4161/cc.23046 · Cited by 12
Self-citationPreferential Killing of Tetraploid Colon Cancer Cells by Targeting the Mitotic Kinase PLK1
Jèmaà, M., Kifagi, C., Serrano, S. S., & Massoumi, R. (2020) · Cellular Physiology and Biochemistry · doi:10.33594/000000221 · Cited by 11
Cytofluorometric Purification of Diploid and Tetraploid Cancer Cells
Castedo, M., Galluzzi, L., Vitale, I., Senovilla, L., Métivier, D., Jèmaà, M., Rello‐Varona, S., & Kroemer, G. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-182-6_3 · Cited by 10
Self-citationSmyth, L. M. L., Rogers, P. A. W., Crosbie, J. C., & Donoghue, J. F. (2017) · Radiation Research · doi:10.1667/rr4633.1 · Cited by 9
“Strategies include the inhibition of Chk1 (48), targeting mitotic kinesin Eg5 (49), the induction of cellspecific autophagy (50) and targeting elevated levels of reactive oxygen species with antioxidants (51).”
BackgroundTetraploidy in normal tissues and diseases: mechanisms and consequences
Kirsch‐Volders, M., Mišík, M., & Fenech, M. F. (2025) · Chromosoma · doi:10.1007/s00412-025-00829-1 · Cited by 9
“For example, i n vitro studies showed that inhibition of Chk1 kills tetraploid tumor cells through a p53-dependent pathway (Vitale et al. 2007).”
Pro-apoptotic function of checkpoint kinase-2 in syncytia elicited by the HIV-1 envelope
Séror, C., Raza, S. Q., Brottes, F., Subra, F., Piacentini, M., Perfettini, J., & Kroemer, G. (2009) · Cell Cycle · doi:10.4161/cc.8.3.7642 · Cited by 9
Self-citationReversible regulation of ORC2 SUMOylation by PIAS4 and SENP2
Wang, R., Liu, F., Zhao, Y., Wu, D., Chen, L., Yeh, E. T. H., & Huang, C. (2017) · Oncotarget · doi:10.18632/oncotarget.19594 · Cited by 6
“For instance, p53 is critical for initiates senescence or apoptosis induced by formation of tetraploidy that is caused by cell fusion, endoreplication, or endomitosis [9–11].”
Losmapimod: A Novel Clinical Drug to Overcome Gefitinib-Resistance
Nishimura, Y. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.01.019 · Cited by 4
“On the other hand, recent reports have suggested that genomic instability, involving a tetraploidization leading to the cell survival, would be the cause of cancer cell growth (Hanahan and Weinberg, 2011; Vitale et al., 2007).”
BackgroundYaguchi, K., Yamamoto, T., Shimada, M., Sugimoto, R., Nakamura, K., Ayabe, T., & Uehara, R. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.08.160 · Cited by 4
Mitotic Spindle as Therapeutic Target for Tetraploid Cancer Cells
Jèmaà, M. (2021) · Eurasian Journal of Medicine and Oncology · doi:10.14744/ejmo.2021.13872 · Cited by 3
“This cytotoxicity occurs after a SAC delay, P53 activation and mitotic catastrophe.[29] Concluding Remarks”
BackgroundSrivastava, S. K., Yadav, M., Singh, P., Tripathi, S., Verma, A. K., & Parmar, A. S. (2026) · Nanoscale Advances · doi:10.1039/d5na00964b · Cited by 4
Wavelet Feature Extraction and Genetic Algorithm for Biomarker Detection in Colorectal Cancer DataPreprint
Liu, Y., Aickelin, U., Feyereisl, J., & Durrant, L. G. (2016) · SSRN Electronic Journal · doi:10.2139/ssrn.2823262 · Cited by 2
Mechanism of mitotic catastrophe and its role in anticancer therapy
Warda, K., Klimaszewska‐Wiśniewska, A., Grzanka, A., & Grzanka, D. (2020) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.5604/01.3001.0014.1328 · Cited by 2
Efeitos da Inibição de Genes Associados ao Controle do Ciclo Celular em Glioblastoma
Morales, A. G. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2012.tde-22042013-093522
Bei, Z. (2013) · edoc (University of Basel) · doi:10.5451/unibas-006145433
“When the extent of damage is limited, cisplatin adducts induce an arrest in the S and G2 phases of the cell cycle, a phenomenon that exerts cytoprotective effects by (1) allowing repair mechanisms to re-establish DNA integrity and (2) preventing potentially abortive or abnormal mitoses [95].”
BackgroundSelective targeting of cancer cells through inhibition of Checkpoint kinase 1
Hasvold, G. (2012) · NVA (Nasjonalt vitenarkiv)
Karyotypic divergence confounds cellular phenotypes in large pharmacogenomic studiesPreprint
Quevedo, R., El-Hachem, N., Smirnov, P., Safikhani, Z., Pugh, T. J., & Haibe‐Kains, B. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/574350
Hoffmann, J., Vitale, I., Buchmann, B., Galluzzi, L., Schwede, W., Senovilla, L., Skuballa, W., Vivet, S., Lichtner, R. B., Vicencio, J. M., et al. (2023) · doi:10.1158/0008-5472.22375373.v1
Self-citationHoffmann, J., Vitale, I., Buchmann, B., Galluzzi, L., Schwede, W., Senovilla, L., Skuballa, W., Vivet, S., Lichtner, R. B., Vicencio, J. M., et al. (2023) · doi:10.1158/0008-5472.22375373
Self-citationChimiothérapie ciblant les cellules cancéreuses p53 déficientes
Jèmaà, M. (2012) · theses.fr (ABES) · doi:10.70675/d5d7f17azc15cz4e7az80a7z617746909a2d
Identification of New Oncogenes Involved in the Tumoral Progression of Breast Carcinoma
Mahmood, S. F. (2012) · theses.fr (ABES) · doi:10.70675/6245fe6cz59ebz47a0za5d9zed3f18e77455
Molecular characterization of entosis
Raza, S. Q. (2012) · theses.fr (ABES) · doi:10.70675/440805b7zcb21z435cz859az09c89e0f972a
Le resvératrol et l’aspirine éliminent les cellules tétraploïdes pour la chimioprévention du cancer
Lissa, D. (2014) · theses.fr (ABES) · doi:10.70675/df75c06bz5b20z46e5za079za31b7439ba68
Mécanismes de l’immunogénicité des cellules cancéreuses hyperploïdes
Bloy, N. (2017) · theses.fr (ABES) · doi:10.70675/f4b9652fz3276z4ef3za505zc0c345e35e95
Tetraploidy in cancer: Diagnostic and therapeutic perspectives
Lessa, A., Levergeois, R., Muñoz-García, J., Mountford, J., Vargas-Franco, J. W., Cochonneau, D., Renodon‐Cornière, A., Heymann, M., Giurgea, I., Heymann, D., et al. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118157
Role of the immune receptor CD47 in mouse model of non-infectious uveitis
Che, Y. (2026) · theses.fr (ABES) · doi:10.70675/7c36bc77zbcf8z4d6ez988dzdd814ec9a952
Mps1 Inhibition Preferentially Induces DNA Damage in Tetraploid Cancer Cells
Jèmaà, M., Lahlaoui, Y., Khemiri, R., Gassem, T., & Kitar, G. (2026) · Biomedicine & Healthcare Research
Metadata
- Authors
- Vitale, I., Galluzzi, L., Vivet, S., Nanty, L., Dessen, P., Senovilla, L., Olaussen, K. A., Lazar, V., Prudhomme, M., Golsteyn, R. M., Castedo, M., & Kroemer, G.
- Affiliations
- Université Paris-Sud (FR)
- Inserm (FR)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Kroemer, Guido
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-12-26
- Volume
- 2
- Issue
- 12
- Pages
- e1337
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2131784
- OpenAlex
- W1978860052
- Cited by
- 77
- References
- 62
- Citations by year
- 2026: 2 · 2025: 1 · 2023: 3 · 2021: 5 · 2020: 5 · 2019: 2 · 2018: 6 · 2017: 4 · 2016: 2 · 2015: 4 · 2014: 4 · 2013: 6 · 2012: 10
- FWCI
- 2.35
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Association pour la Recherche sur le Cancer
- Institut National Du Cancer
- Institut Gustave-Roussy
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- tetraploidy, CHK1 inhibition, p53 activation, spindle assembly checkpoint, aberrant mitosis, mitochondrial apoptosis, cisplatin resistance, colon cancer, BUB1, BubR1, Mad2, genotoxic stress resistance, tumor cell killing
- MeSH terms
- Checkpoint Kinase 1, Cisplatin, Humans, Spindle Apparatus, Polyploidy, Protein Kinases, Signal Transduction, Tumor Suppressor Protein p53, Apoptosis, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.